ProfessorMainthan Palendira
Academic Director, Sydney Cytometry
DVC Research
Orcid identifier0000-0002-1113-3306 (opens in a new tab)
- Academic Director, Sydney CytometryDVC Research
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONAnalysing the tumour microenvironment of hepatocellular carcinoma
- RESEARCH-BASED DEGREE SUPERVISIONAssessing the function of tumour specific and bystander T-cells in relation to clinical outcomes of melanoma patients
- RESEARCH-BASED DEGREE SUPERVISIONDefining the role of T helper responses in immune checkpoint blockade therapies and associated immune-related adverse events
- RESEARCH-BASED DEGREE SUPERVISIONDefining the tumour microenvironment landscape of melanoma immunotherapy
- RESEARCH-BASED DEGREE SUPERVISIONImmune Landscape of Mycobacterial Granulomas
- RESEARCH-BASED DEGREE SUPERVISIONInvestigating the role of IL-17 family of cytokines in the proliferation and differentiation of secretary epithelium during early life
- RESEARCH-BASED DEGREE SUPERVISIONMapping the Cellular and Spatial Landscape of Metastatic Melanoma
- RESEARCH-BASED DEGREE SUPERVISIONMechanisms of immune checkpoint inhibitor-induced gastrointestinal toxicities
- RESEARCH-BASED DEGREE SUPERVISIONMechanisms of response and resistance to anti-PD-1 immunotherapy
- RESEARCH-BASED DEGREE SUPERVISIONOptimising Neutron Capture Therapy to Modulate the Immunosuppressive Tumour Microenvironment of Glioblastoma
- RESEARCH-BASED DEGREE SUPERVISIONPathogenesis of Neurovascular Lesions in Multiple Sclerosis: ex vivo and in vitro studies
- RESEARCH-BASED DEGREE SUPERVISIONThe Tumour Microenvironment of Mucosal Head and Neck Squamous Cell Carcinoma and its Influence on Immune Checkpoint Inhibitor Response
- RESEARCH-BASED DEGREE SUPERVISIONTissue Resident T Cells In Human Disease
- RESEARCH-BASED DEGREE SUPERVISIONUnderstanding B cells in pMHC-specific allorecognition
- RESEARCH-BASED DEGREE SUPERVISIONUnderstanding the Immune and Stromal Microenvironment in Hepatocellular Carcinoma (HCC) recurrence and response to therapy